BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Aflibercept
1
Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture
4/9/2021 8:11:25 AM | Browse: 969 | Download: 2418
2
Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer
2/22/2019 4:33:37 AM | Browse: 1246 | Download: 2093
3
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
2/22/2019 4:33:37 AM | Browse: 1258 | Download: 1560
4
FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer
9/14/2018 11:38:00 AM | Browse: 1266 | Download: 2442
5
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 1312 | Download: 2332
6
Treatment of diabetic retinopathy: Recent advances and unresolved challenges
8/23/2016 8:55:00 AM | Browse: 1380 | Download: 2310
7
New active drugs for the treatment of advanced colorectal cancer
12/24/2015 8:55:00 AM | Browse: 1186 | Download: 2167
8
Curing diabetic retinopathy: Is a strategy emerging?
11/13/2015 3:33:00 PM | Browse: 1578 | Download: 2325
9
Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives
9/11/2014 8:40:00 PM | Browse: 1302 | Download: 1872
10
Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema
9/1/2014 2:50:00 PM | Browse: 1301 | Download: 1533
11
Advances and new perspectives in the treatment of metastatic colon cancer
8/26/2014 4:37:00 PM | Browse: 1494 | Download: 1892
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.